LGALS3 and coronary artery disorder: A 26-month study involving patients with chronic heart failure and CAD revealed that galectin-3 values > 21 ng/mL were associated with elevated mortality risk, establishing galectin-3’s independence as a predictor for mortality from all causes and rehospitalization [118,122].